Your research, our priority: PHARMExcel’s commitment to delivering quality every time
Hear how PHARMExcel strikes the right balance between quality and speed for its clinical trial delivery
ATMP Oncology Study: The first-in man trial for a Biotech’s novel therapy to prime the patient’s natural killer cells to attack their cancer
First-in-man clinical trial for INmune Bio’s novel therapy to prime the patient’s natural killer cells to attack their cancer.
PHARMExcel named finalist for Most Impactful CRO of the Year at OBN Awards
PHARMExcel nominated for Most Impactful CRO in OBN Life Sciences Awards
PHARMExcel and Moorfields Eye Hospital: a visionary partnership in ophthalmology clinical research
For over 16 years, PHARMExcel and Moorfields Eye Hospital have collaborated to push the boundaries of ophthalmology clinical research. Discover how this visionary alliance is accelerating quality clinical trial outcomes.
The challenges of financial forecasting in a growing CRO
PHARMExcel’s newest paper in Frontline Gastroenterology is now available
We’re thrilled to announce our newest paper in Frontline Gastroenterology is now published online.
Forging paths: a closer look at rare disease clinical trials in the UK
Forging Paths: A Closer Look at Rare Disease Clinical Trials in the UK and role CROs can play.
What does a world-class research site look like from a CRO-Sponsor perspective?
How can CROs and Sponsors support UK sites to deliver world-class research?
PHARMExcel’s CEO returns to speak at Clinical Outsourcing Group Conference 2024
PHARMExcel’s CEO, Yvanne Enever, returns to speak at Clinical Outsourcing Group Conference 2024.